Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2022 17:00 ET | Source: Conformis, Inc.

Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer

BILLERICA, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to...
March 22, 2022 08:00 ET | Source: Conformis, Inc.

Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients

BILLERICA, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic...
March 14, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary

BILLERICA, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate Secretary. “We...
March 11, 2022 08:00 ET | Source: Conformis, Inc.

Gary Fischetti nominated to join Conformis’ Board of Directors

BILLERICA, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of...
March 02, 2022 16:05 ET | Source: Conformis, Inc.

Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
March 02, 2022 08:00 ET | Source: Conformis, Inc.

Conformis Suspends All Distribution Operations and Business Development in Russia

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its...
February 28, 2022 08:00 ET | Source: Conformis, Inc.

New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1

BILLERICA, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published...
February 24, 2022 08:00 ET | Source: Conformis, Inc.

Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel

BILLERICA, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced...
February 18, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in Upcoming Investor Conferences

BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
January 20, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022

BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial...